Immunogenicity 15302
Sample ID
patient3
Response
Negative
Tumor Type
Melanoma
Gene Symbol
BCS1L
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (419 aa)
MPLSD
1
FILAL
6
KDNPY
11
FGAGF
16
GLVGV
21
GTALA
26
LARKG
31
VQLGL
36
VAFRR
41
HYMIT
46
LEVPA
51
RDRSY
56
AWLLS
61
WLTRH
66
STRTQ
71
HLSVE
76
TSYLQ
81
HESGR
86
ISTKF
91
EFVPS
96
PGNHF
101
IWYRG
106
KWIRV
111
ERSRE
116
MQMID
121
LQTGT
126
PWESV
131
TFTAL
136
GTDRK
141
VFFNI
146
LEEAR
151
ELALQ
156
QEEGK
161
TVMYT
166
AVGSE
171
WRPFG
176
YPRRR
181
RPLNS
186
VVLQQ
191
GLADR
196
IVRDV
201
QEFID
206
NPKWY
211
TDRGI
216
PYRRG
221
YLLYG
226
PPGCG
231
KSSFI
236
TALAG
241
ELEHS
246
ICLLS
251
LTDSS
256
LSDDR
261
LNHLL
266
SVAPQ
271
QSLVL
276
LEDVD
281
AAFLS
286
RDLAV
291
ENPVK
296
YQGLG
301
RLTFS
306
GLLNA
311
LDGVA
316
STEAR
321
IVFMT
326
TNHVD
331
RLDPA
336
LIRPG
341
RVDLK
346
EYVGY
351
CSHWQ
356
LTQMF
361
QRFYP
366
GQAPS
371
LAENF
376
AEHVL
381
RATNQ
386
ISPAQ
391
VQGYF
396
MLYKN
401
DPVGA
406
IHNAE
411
SLRR
416
Mutation Information
DNA mutation:
None
Peptide Range:
30 ~ 38
Mut AA position:
33 (4 in Wild Type peptide)
Alignment
Wild Type:
"ALARKGVQL
|||.|||||
Mutant:
ALAQKGVQL"
Science, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresGene Name (from Reference) BCS1L
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
MoDCs
Assay
IFNg ELISPOT assay